Investment of the week: Jnana Therapeutics launches with a US$ 50 m Series A investment to target th
The Boston-based biotech Jnana Therapeutics just announced its launch with a US$ 50m Series A financing. Its focus will be to build the...
Wet AMD, an unmet medical need that can benefit from the discovery of novel small molecules
Age-related macular degeneration (AMD) is a common eye condition that causes damage to the macula, which is a small light-sensitive area...
Investment of the week: Warp Drive Bio forms a collaboration with Roche
In October 2017 was announced that Warp Drive Bio, a drug discovery company developing therapeutics that exploit the molecules and...
The hype of microbiome in drug discovery
In the last 15 years, there has been a growing understanding that the composition of the large populations of bacteria and other...
The unmet medical need of antimicrobial resistance
The development and spread of antimicrobial resistance is a complex issue to which the costs of inaction are huge. A recent review on...